PFKFB3 and neoplasm: It has been shown that genetic or pharmacological inhibition on PFKFB3 attenuates glycolytic flux and induces prosurvival autophagy in colon and gynecological cancer in vitro and in vivo, thus limiting tumor’s sensitivity to chemotherapy [25,26,27,28,29,30].